Dr Eric Nepute interviews Dr. Lawrence Palevsky MD, world-renowned pediatrician and outspoken advocate for healthcare freedoms.
Catch the Interview Here:
(Professor of Medicine and Professor of Epidemiology and Population Health, as well as Professor by Courtesy of Biomedical Data Science at Stanford University School of Medicine,)
Dr. Palevsky’s Comments: Non-elected, non-scientific, non-medical citizens, suggesting/making medical decisions and setting policy. Don’t for a second believe we are being governed any longer. This is a ruling state. I suggest paying attention…….
Infectivity of CoVID-19 (SARS CoV-2) shown to be surprisingly WEAK: In this study they actually tried to infect 455 people via people who were infected, and they failed 100%. So NOBODY in the study successfully transferred CoVID-19 to any of the 455 people they tried to infect. “Conclusion: In summary, all the 455 contacts were excluded from SARS-CoV-2 infection and we conclude that the infectivity of some asymptomatic SARS-CoV-2 carriers might be weak.”
Top immunologist, Prof. Dolores Cahill, Discusses Natural Immunity and More.
Top Immunologist, Prof. Dolores Cahill, backs a stunning claim made by scientist Judy Mikovits in the censored viral video #Plandemic, explaining in detail how coronavirus, and other viruses, may be contaminating the seasonal flu shot.
Q: Are Antibody, or Serology, Tests Used to Diagnose SARS-CoV-2 Infection?
A: The terms "serological" or "antibody" tests are generally used to refer to tests that detect antibodies to the SARS-CoV-2 virus. Because the antibodies are part of the body's immune response to exposure and not the virus itself, such testing cannot be used for diagnosis of infection. Based on the underlying scientific principles of antibody tests, we do not expect that an antibody test can be shown to definitively diagnose or exclude COVID-19 infection. SARS-CoV-2 antibody tests are intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, by detecting antibodies to SARS-CoV-2 in human blood specimens.
As stated in the Policy for Coronavirus Disease-2019 Tests, validated antibody tests offered under the policy in that guidance should, among other things, include in instructions for use and test reports information to convey that negative results do not preclude acute SARS-CoV-2 infection and that, if acute infection is suspected, direct testing for SARS-CoV-2 is necessary. SARS-CoV-2 serology tests should be ordered only by clinicians who are familiar with the use and limitations of the test.